Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$102,908,703
+$23,133,372 QoQ
Shares Held
85,798
-1.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#380
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC holds $356,211,589 across 11 Drug Manufacturers - General names. LLY ranks #1 (28.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
85,798 | $102,908,703 | |
| 2 | JNJ |
Johnson & Johnson
|
274,074 | $69,606,573 | |
| 3 | ABBV |
AbbVie Inc.
|
201,432 | $50,688,348 | |
| 4 | MRK |
Merck & Co., Inc.
|
254,075 | $32,648,637 | |
| 5 | AZN |
Astrazeneca PLC
|
138,649 | $26,290,623 | |
| 6 | AMGN |
Amgen Inc
|
55,938 | $20,256,268 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
157,741 | $19,928,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
273,712 | $15,771,285 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,908,703 | 85,798 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $79,775,331 | 86,734 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $94,355,838 | 87,799 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $67,197,410 | 88,070 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $71,872,666 | 92,200 | Shares | Sole | 2025-07-29 | |
| 2024-12-31 | $74,767,428 | 96,849 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $88,409,724 | 99,792 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $94,581,427 | 104,466 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $84,895,662 | 109,126 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $64,646,993 | 110,902 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $62,350,587 | 116,081 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $55,346,674 | 118,015 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $40,409,887 | 117,669 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $43,037,051 | 117,639 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $36,999,000 | 114,424 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $36,564,389 | 112,773 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $31,910,209 | 111,430 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $30,469,551 | 110,309 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $25,415,037 | 109,998 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $25,178,573 | 109,701 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $20,378,512 | 109,081 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $17,969,472 | 106,429 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,231,281 | 109,656 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $20,490,649 | 124,806 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $21,444,169 | 154,586 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||